E-Mail 'Bayer's Stivarga OK'd for Colon Cancer' To A Friend

Email a copy of 'Bayer's Stivarga OK'd for Colon Cancer' to a friend

* Required Field






Separate multiple entries with a comma. Maximum 5 entries.



Separate multiple entries with a comma. Maximum 5 entries.


E-Mail Image Verification

Loading ... Loading ...
(MedPage Today) -- Regorafenib (Stivarga), an inhibitor of multiple kinase enzymes, has been approved for use in treatment-refractory, metastatic colorectal cancer, the FDA announced Wednesday.

Bayer’s Stivarga OK’d for Colon Cancer

(MedPage Today) — Regorafenib (Stivarga), an inhibitor of multiple kinase enzymes, has been approved for use in treatment-refractory, metastatic colorectal cancer, the FDA announced Thursday.